Advantage Solutions Inc.
For the period ended Dec 31, 2025. Filed Mar 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 3, 2026
ADV$32.29-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2023 |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net loss from continuing operations | $(227,735) | $(378,404) | $(81,211) |
| Adjustments to reconcile net loss to net cash provided by operating activities | |||
| Non-cash adjustments on derivatives and non-cash interest expense (income) | (2,102) | 5,227 | (7,728) |
| Amortization of deferred financing fees | 7,038 | 6,766 | 8,292 |
| Impairment of goodwill and indefinite-lived asset | 203,685 | 275,170 | 43,500 |
| Depreciation and amortization | 202,258 | 204,553 | 208,856 |
| Fair value adjustments related to contingent consideration | — | 1,678 | 11,152 |
| Deferred income taxes | (57,521) | (57,307) | (80,416) |
| Equity-based compensation of Karman Topco L.P. | (1,524) | 723 | (2,524) |
| Stock-based compensation | 26,915 | 31,019 | 38,933 |
| Income from equity method investments | (7,491) | (2,064) | (5,511) |
| Distribution received from equity method investments | 1,810 | 3,289 | 2,100 |
| Gain on divestiture and deconsolidation of subsidiaries | (27,983) | — | (58,891) |
| Gain on repurchases of Senior Secured Notes and Term Loan Facility debt | (1,649) | (9,141) | (8,665) |
| Other | 282 | 1,769 | 3,032 |
| Changes in operating assets and liabilities, net of effects from divestitures: | |||
| Accounts receivable, net | 7,995 | 51,154 | 38,899 |
| Prepaid expenses and other assets | (31,423) | 28,396 | 100,841 |
| Accounts payable | 5,271 | (12,918) | (23,066) |
| Accrued compensation and benefits | (10,665) | (30,380) | 27,458 |
| Deferred revenues | 7,335 | (2,129) | 8,551 |
| Other accrued expenses and other liabilities | (32,964) | (24,306) | 4,890 |
| Net cash provided by operating activities | 61,532 | 93,095 | 228,492 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Purchase of investments in unconsolidated affiliates | (3,736) | (13,932) | (3,023) |
| Purchase of property and equipment | (6,477) | (7,838) | (20,691) |
| Purchase and development of capitalized software | (46,434) | (47,501) | (20,872) |
| Proceeds from divestitures | 60,491 | 275,717 | 21,108 |
| Deconsolidation of subsidiaries cash and cash equivalents and restricted cash, net of proceeds | — | — | (31,465) |
| Proceeds from sale of investments in unconsolidated affiliates | — | — | 4,428 |
| Net cash (used in) provided by investing activities | 3,844 | 206,446 | (50,515) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Borrowings under lines of credit | 90,000 | — | 99,538 |
| Payments on lines of credit | (90,000) | — | (99,102) |
| Principal payments on long-term debt | (13,250) | (13,131) | (13,294) |
| Repurchases of Senior Secured Notes and Term Loan Facility debt | (18,218) | (147,122) | (156,559) |
| Debt issuance costs | — | (971) | — |
| Deferred consideration paid for purchases in unconsolidated affiliates | (2,113) | — | — |
| Contingent consideration payments | — | (5,655) | (1,867) |
| Proceeds from employee stock purchase plan | 1,838 | 2,294 | 2,248 |
| Payments for taxes related to net share settlement of equity awards | (3,596) | (12,765) | (1,880) |
| Holdback payments | — | — | (944) |
| Redemption of noncontrolling interest | — | — | (154) |
| Purchase of treasury stock | (869) | (34,067) | (6,382) |
| Net cash used in financing activities | (36,208) | (211,417) | (178,396) |
| Net effect of foreign currency changes on cash, cash equivalents and restricted cash | 3,068 | (4,575) | 1,800 |
| Net change in cash, cash equivalents and restricted cash | 32,236 | 83,549 | 1,381 |
| Cash, cash equivalents and restricted cash, beginning of period | 220,751 | 137,202 | 135,821 |
| Cash, cash equivalents and restricted cash, end of period | $252,987 | $220,751 | $137,202 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.